Else Nutrition Holdings Inc. (0YL.F)
| Previous Close | 0.1530 |
| Open | 0.1520 |
| Bid | 0.1630 x N/A |
| Ask | 0.1820 x N/A |
| Day's Range | 0.1520 - 0.1620 |
| 52 Week Range | 0.1090 - 0.5400 |
| Volume | |
| Avg. Volume | 120 |
| Market Cap | 27.053M |
| Beta (5Y Monthly) | 2.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0900 |
| Earnings Date | May 13, 2024 - May 17, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: Else Nutrition Holdings Inc
Announces the first roll-out of its infant formula in Australia and New Zealand, setting the stage for ...
GlobeNewswireElse Nutrition Announces Highly Anticipated First Commercial Launch of its Groundbreaking Plant-Based Infant Formula in Australia; Also Targeting $50B (USD) Plus Asia Pacific Baby & Child Nutrition Markets
Australia Strategically Selected as Beachhead for Commercial Expansion of Else Products Across the Asia Pacific Region Amazon First to Carry Else’s New ‘Follow-On’ Formula (6-12m) for Infants and ‘Toddler Drink’ (12-36m) in Australia VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) is proud to announce the official commercial launch of its first-in-class ‘Follow-On’ formula for infants ages 6-12 months i
GlobeNewswireElse Nutrition Reports 2023 Financial Results and Provides Business Update
Achieves 38% Sequential Increase in Revenue for Q4 2023 Compared to Q3 2023 Revenue Increases 10% in 2023 compared to 2022 Conference Call to be Held Today at 10:30 AM Eastern Time VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today reported financial results for the fourth quarter and year ended December 31, 2023. The financial statements and MD&A are available on SEDAR under the Company’s profile.
